Results 31 to 40 of about 156,559 (321)

Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea

open access: yesArthritis Research & Therapy, 2021
Background This study aimed to evaluate the crude incidence rates and relative risk of malignancy in Korean patients with SLE. Methods We conducted a retrospective nationwide cohort study using databases from the National Health Insurance Service in ...
Jung-Yong Han   +5 more
doaj   +1 more source

Sustained Drug Free Remission of Lupus Panniculitis with Methotrexate: A Report From Nepal

open access: yesJournal of Nepal Medical Association, 2018
Cutaneous manifestations are second most common presenting feature of lupus. Discoid lupus erythematosus is the most common variant amongst all; lupus panniculitis being described in only 2-5% of cases.
Binit Vaidya   +3 more
doaj   +1 more source

3D Patient-specific Modelling and Characterisation of Muscle-Skeletal Districts [PDF]

open access: yesarXiv, 2023
This work addresses the patient-specific characterisation of the morphology and pathologies of muscle-skeletal districts (e.g., wrist, spine) to support diagnostic activities and follow-up exams through the integration of morphological and tissue information.
arxiv  

In Silico Investigation of Phytoconstituents from Indian Medicinal Herb 'Tinospora cordifolia (Giloy)' against SARS-CoV-2 (COVID-19) by Molecular Dynamics Approach [PDF]

open access: yes, 2020
The recent appearance of COVID-19 virus has created a global crisis due to unavailability of any vaccine or drug that can effectively and deterministically work against it. Naturally, different possibilities (including herbal medicines having known therapeutic significance) have been explored by the scientists.
arxiv   +1 more source

Osteoporosis and rheumatic diseases

open access: yesReumatismo, 2014
Numerous rheumatic diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis/polymyositis and vasculitis are characterized by osteoporosis and fragility fractures. Inflammatory cytokines, glucocorticoid treatment, immobilization
Maruotti N.   +2 more
openaire   +7 more sources

Genetics of rheumatic disease [PDF]

open access: yesArthritis Research & Therapy, 2009
Many of the chronic inflammatory and degenerative disorders that present to clinical rheumatologists have a complex genetic aetiology. Over the past decade a dramatic improvement in technology and methodology has accelerated the pace of gene discovery in complex disorders in an exponential fashion.
Alexander J. Clarke, Timothy J. Vyse
openaire   +3 more sources

Consensus of Chinese Experts on the Diagnosis and Treatment of Type Ⅰ Interferonopathy

open access: yes罕见病研究
Type Ⅰ interferonopathy is an autoinflammatory disease that affects multiple systems, with a high disability and mortality rate. It profoundly impacts the quality of life of patients and poses a considerable burden on their families and society.
Chinese Alliance of Pediatric Rheumatic & Immunologic Diseases   +1 more
doaj   +1 more source

Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report

open access: yesClinical Case Reports, 2020
We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients.
Akihiro Yamada   +2 more
doaj   +1 more source

Glycosylation and rheumatic disease

open access: yesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
Rheumatoid arthritis (RA) and other rheumatic diseases are associated with a significant defect in the galactosyltransferase enzyme that results in a profound change in the galactosylation of immunoglobulin G. This change has been demonstrated to be integrally associated with pathogenic mechanisms associated with inflammation in RA.
openaire   +5 more sources

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients

open access: yesArthritis Research & Therapy, 2021
Objective To evaluate the effectiveness of bazedoxifene in preventing bone loss in patients with rheumatoid arthritis (RA) receiving low-dose glucocorticoids (GCs).
Soo-Kyung Cho   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy